Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 29 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Phase II Chemotherapy with Spirogermanium for Advanced Gynecologic Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				70 and under								UMCC-8036


2.		Phase II Master Protocol to Evaluate Chemotherapeutic Agents or Combinations for Refractory Malignant Glioma --- SPG

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified				NCI				EST-1382


3.		Phase II Chemotherapy with Spirogermanium for Advanced Stage III/IV Adenocarcinoma of the Breast

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified				NCI				EST-PB-181 WCCC-CO-8012


4.		Phase II Master Protocol Chemotherapy with New Single Agents in Patients with Stage II/III non-Small Cell Carcinoma of the Lung --- Spirogermanium

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified				NCI				ICC-81L3 NCI-T83-0925D, T83-0925


5.		Phase II Chemotherapy with Spirogermanium in Metastatic Lung Cancer of All Histologies

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				15 and over								MDA-DM-8287 NCI-C83-0419


6.		Phase II Chemotherapy with Spirogermanium for Metastatic Malignant Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified				NCI				SWOG-8240


7.		Phase II Chemotherapy with Spirogermanium for Renal Cell Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified				NCI				SWOG-8218


8.		Phase II Chemotherapy with Spirogermanium for Metastatic Gastric, Colorectal, and Miscellaneous Gastrointestinal Malignant Neoplasms

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				15 and over								MDA-DT-8173 NCI-C83-0555

Last Modified: 6/1/1997


9.		Phase II Master Protocol for Single-Agent Chemotherapy for Previously Treated Stage III/IV Hodgkin's and non-Hodgkin's Lymphoma --- PALA, AMSA, SPG, DCF (Summary Last Modified 06/97).

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				15 to 76				NCI				EST-1480

Last Modified: 6/1/1997


10.		Phase II Master Protocol Chemotherapy for Metastatic or Recurrent Gastric Cancer --- VP-16 vs DHAD (Summary Last Modified 06/97).

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				no age specified				NCI				EST-5282

Select All on One Page


					1 2 3 Next >

| | | | | | | |

A Service of the National Cancer Institute